skip to Main Content

EUROQOL | News

Study team appointed for the new UK EQ-5D-5L valuation study

The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s…

Read more...

EQ-5D is the most commonly cited multi-attribute utility instrument in review of national pharmacoeconomic guidelines

A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health…

Read more...

First EuroQol approved sign language version of the EQ-5D-5L is now available

EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…

Read more...

The 2nd EuroQol Asia Academy Meeting is postponed until 2021

In light of current situation of the Covid-19 in around the globe, where some countries (e.g., Singapore) are having second wave and in some others (e.g., Indonesia, Malaysia, India) the measures being implemented by the…

Read more...

Chinese version of the EQ-5D-5L User Guide now available for download

The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include…

Read more...

International valuation protocol for the EQ-5D-Y published

EuroQol is pleased to announce that, following an extensive programme of methodological research, an international evidence-based valuation protocol has been developed for the EQ-5D-Y instrument. Published in PharmacoEconomics, the new valuation protocol will enable the…

Read more...

EQ-5D licenses for COVID-19 related research

EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19. The EQ Office Team is handling all requests for using…

Read more...

Notice to website visitors and customers

As a result of the Covid-19 crisis the EuroQol Office team is working from home. We are doing our best to guarantee the level of service that you have become accustomed to. However, the current…

Read more...

Extending deadline Call for Abstracts for the 37th EQ Plenary Meeting 2020 in Chicago

In light of the Covid-19 crisis emerging worldwide, we kindly inform you that the deadline for submitting abstracts for the 37th EuroQol Plenary Meeting on 16-19 September 2020 in Chicago is postponed to Monday 11…

Read more...

EuroQol launches a new whiteboard animation, ‘How to obtain EQ-5D’.

EuroQol is pleased to launch a new whiteboard animation, ‘How to obtain EQ-5D’. The animation is intended for anyone interested in using EQ-5D. It describes the process of registering and gaining access to the instrument,…

Read more...
Back To Top
×Close search
Search